Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Andain Inc. Announces 2,000 Units Initial Production of the Breakthrough Miniature Disposable Insulin Pump for Use in Clinical Trials for Type-I and Type-II Diabetes
Andain Inc. (OTCBB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in the fields of biotech, medical and life sciences through its accelerating incubator program, announced today the production of 2,000 miniature disposable insulin pump units for clinical trials.
The diabetes management products market, including insulin injection devices and insulin pumps, insulin therapies and oral and injectable diabetes drugs-have become one of the largest medical device markets in the U.S. totaling more than $20 billion in 2008. The insulin pump market is sizeable and rapidly growing. Global markets sales are estimated to be over $1 billion annually with a 12% compound annual growth rate.
Andain's technological industrial accelerating incubator, has assembled 2,000 units of its miniature disposable insulin pump for type-I and type-II diabetes to be used in forthcoming clinical trials.
http://www.sacbee.com/2013/06/10/5485154/andain-inc-announces-2000-units.html
Andain Inc. (OTCBB: ANDN) ("Andain"), a company engaged in commercializing novel technologies in the fields of biotech, medical and life sciences through its accelerating incubator program, announced today the production of 2,000 miniature disposable insulin pump units for clinical trials.
The diabetes management products market, including insulin injection devices and insulin pumps, insulin therapies and oral and injectable diabetes drugs-have become one of the largest medical device markets in the U.S. totaling more than $20 billion in 2008. The insulin pump market is sizeable and rapidly growing. Global markets sales are estimated to be over $1 billion annually with a 12% compound annual growth rate.
Andain's technological industrial accelerating incubator, has assembled 2,000 units of its miniature disposable insulin pump for type-I and type-II diabetes to be used in forthcoming clinical trials.
http://www.sacbee.com/2013/06/10/5485154/andain-inc-announces-2000-units.html